Pubblicazioni

The impact of radiotherapy and attenuated chemotherapy regimens in older patients with classic hodgkin lymphoma. A real-life study from the ReLLi Network

2025 - CANCERS

Cox, M. C.; Caridi, M.; Patirelis, A.; Del Giudice, I.; Pulsoni, A.; Renzi, D.; Pelliccia, S.; Battistini, R.; Anticoli Borza, P.; Annibali, O.; Rapisarda, V.; Alma, E.; Messina, N.; D'Elia, G. M.; Marchesi, F.; Cenfra, N.; Bianchi, M. P.; Natalino, F.; Carpaneto, A.; Assanto, G. M.; Zizzari, A. G.; Maiolo, E.; De Sanctis, V.; Hohaus, S.; Rigacci, L.

Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review

2022 - FRONTIERS IN ONCOLOGY

Rizzo, S.; Raia, G.; Del Grande, M.; Gasparri, M. L.; Colombo, I.; Manganaro, L.; Papadia, A.; Del Grande, F.

Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: a systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

2021 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

De Felice, F.; Belgioia, L.; Alterio, D.; Bonomo, P.; Maddalo, M.; Paiar, F.; Denaro, N.; Corvo, R.; Merlotti, A.; Bossi, P.; Pappagallo, G. L.; D' Angelillo, R. M.; Magrini, S. M.; Arcangeli, S.